PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 74 filers reported holding PMV PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,177 | +1.7% | 19,247 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $116,198 | +37.0% | 18,562 | +4.4% | 0.00% | 0.0% |
| Q1 2023 | $84,787 | -44.1% | 17,775 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $151,563 | -27.1% | 17,421 | -0.4% | 0.00% | -50.0% |
| Q3 2022 | $208,000 | -15.4% | 17,485 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $246,000 | -9.2% | 17,237 | +32.4% | 0.00% | +100.0% |
| Q1 2022 | $271,000 | -15.8% | 13,023 | -6.6% | 0.00% | -50.0% |
| Q4 2021 | $322,000 | -24.8% | 13,939 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $428,000 | -14.7% | 14,357 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $502,000 | +91.6% | 14,698 | +84.6% | 0.00% | +100.0% |
| Q1 2021 | $262,000 | -46.3% | 7,963 | +0.3% | 0.00% | -50.0% |
| Q4 2020 | $488,000 | – | 7,941 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 4,179,416 | $257,076,000 | 54.42% |
| INTERWEST VENTURE MANAGEMENT CO | 6,469,911 | $397,964,000 | 49.71% |
| Octagon Capital Advisors LP | 250,000 | $15,378,000 | 5.33% |
| Boxer Capital, LLC | 2,268,236 | $139,519,000 | 4.48% |
| COMMODORE CAPITAL LP | 125,000 | $7,689,000 | 4.18% |
| Orbimed Advisors | 7,330,423 | $450,894,000 | 3.95% |
| Asymmetry Capital Management, L.P. | 96,595 | $5,942,000 | 2.71% |
| Avoro Capital Advisors LLC | 2,350,267 | $130,536,000 | 2.25% |
| RA Capital Management | 1,710,265 | $105,198,000 | 1.47% |
| HighVista Strategies LLC | 22,654 | $1,393,000 | 0.89% |